DEF 14A

Company

Nurix Therapeutics, Inc.

Filed

March 28, 2025

Period of Report

May 19, 2025

Accession Number

0001140361-25-010808

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →